Analyzing an Algorithm For HER2 Neu Positive Breast Cancer

In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute. Dr. Hamilton detailed her approach to treating HER 2/Neu positive breast cancer using an algorithm which recommends different treatment options based on disease stage (early stage, locally advanced, advanced disease/metastatic). Additionally, the group reviewed two case studies from the cancer community.